James W.M. Owens, Jr, MD, PhD

Adam Kelly, MD

Accredited by

American Academy of Neurology

Course Description


- Identify clinical features in this study seen in conjunction with high anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in a cohort of children with acquired demyelinating syndromes
- Describe the prognostic role for anti-MOG antibodies in identifying children after an initial demyelinating event who are at high risk of subsequent development of multiple sclerosis (MS) in this study
- Discuss the sensitivity and specificity of anti-MOG antibodies in the diagnosis of non-MS disease courses following an initial demyelinating event observed in this study

Activity Details

Credit Types:CME
Credit Amount:0.75 Credits
Release Date:2017-Aug-29
Expiration Date:2020-Aug-29
Registration Required:Yes

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.